Long-Chain Polyunsaturated Fatty Acid Status at Birth and Development of Childhood Allergy: A Systematic Review

Area of Science:

• Nutritional Immunology
• Pediatric Allergy Research
• Fetal Development Studies

Background:

• The link between fetal fatty acid status and later immune health, particularly childhood allergies, remains insufficiently understood.
• Understanding this relationship is crucial for developing targeted nutritional strategies during pregnancy.

Purpose of the Study:

• To systematically review and synthesize existing evidence on the association between fatty acid status at birth and the incidence of childhood allergies.
• To explore the correlation between specific fatty acids in cord blood and allergic outcomes.

Main Methods:

• A systematic literature search was conducted across major databases: Ovid MEDLINE, Cochrane Library, and Embase.
• Inclusion criteria were applied to filter 897 retrieved articles down to 14 relevant studies.
• Analysis included dichotomous (allergic vs. non-allergic) and linear (odds ratios, relative risks) parameters.

Main Results:

• Lower cord blood eicosapentaenoic acid (EPA) levels were observed in children diagnosed with allergies.
• Higher cord blood levels of EPA, docosahexaenoic acid (DHA), and total n-3 long-chain polyunsaturated fatty acids were associated with a significant reduction (≥38%) in allergy risk.
• Positive associations were found between higher EPA, docosapentaenoic acid, and DHA in cord blood and negative correlations with laboratory markers of allergic traits.

Conclusions:

• Fetal exposure to specific omega-3 fatty acids, particularly EPA and DHA, appears to play a protective role against the development of childhood allergies.
• These findings suggest that maternal fatty acid intake during pregnancy may be a modifiable factor for preventing pediatric allergic diseases.
• Further research into optimal maternal fatty acid supplementation is warranted.